Ziprasidone

Chemical formula: C₂₁H₂₁ClN₄OS  Molecular mass: 412.936 g/mol  PubChem compound: 60854

Therapeutic indications

Ziprasidone is indicated for:

Schizophrenia

Population group: only adults (18 years old or older)

Schizophrenia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Manic or mixed episodes of moderate severity in bipolar disorder

Population group: only adults (18 years old or older)

Moderate manic bipolar I disorder

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Ziprasidone is contraindicated in the following cases:

Lactation

Lactation

Known QT-interval prolongation

Prolonged QT interval

Congenital long QT syndrome

Congenital long QT syndrome

Recent acute myocardial infarction

Acute myocardial infarction

Uncompensated heart failure

Decompensated cardiac failure

Arrhythmias treated with class IA and III antiarrhythmic medicinal products

at least one of
Arrhythmia
Antiarrhythmics, class Ia
Antiarrhythmics, class III

Medicinal products that prolong the QT interval

Drugs prolonging QT interval

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.